The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 353:424-427 July 28, 2005 Number 4
NextNext

Treatment of Mild Asthma

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Fabbri, L. M.
-Related Article
by Boushey, H. A.
-PubMed Citation
To the Editor: Boushey et al. (April 14 issue)1 report that regularly scheduled treatment with budesonide for mild persistent asthma has no significant advantage over intermittent short-course treatment. We compared data from a large pediatric survey of prescriptions for antiasthma drugs,2,3 involving seven Italian regions, with the same kind of information from our region, Friuli-Venezia Giulia. In our region, ours is the regional referral center for pediatric asthma, and we suggest that short courses of controller therapies are preferable to prolonged treatments.4 In our region, the number of prescriptions for inhaled corticosteroids in one year (2003) for children up to . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.